GSK walks away from Ionis antisense drugs

14th August 2017 Uncategorised 0

GlaxoSmithkline has turned down options to take on board Ionis Pharmaceuticals’ experimental antisense therapies inotersen and IONIS-FB-LRx following a pipeline revamp.

More: GSK walks away from Ionis antisense drugs
Source: News